Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Selank

Selanc, TP-7

Quick Stats
Studies 114
Trials 11
2023 pubmed 23 citations

Atrial fibrillation-associated electrical remodelling in human induced pluripotent stem cell-derived atrial cardiomyocytes: a novel pathway for antiarrhythmic therapy development.

Seibertz. Fitzwilliam F; Rubio. Tony T; Springer. Robin R; Popp. Fiona F; Ritter. Melanie M; Liutkute. Aiste A; Bartelt. Lena L; Stelzer. Lea L; Haghighi. Fereshteh F; Pietras. Jan J; Windel. Hendrik H; Pedrosa. Núria Díaz I NDI; Rapedius. Markus M; Doering. Yannic Y; Solano. Richard R; Hindmarsh. Robin R; Shi. Runzhu R; Tiburcy. Malte M; Bruegmann. Tobias T; Kutschka. Ingo I; Streckfuss-Bömeke. Katrin K; Kensah. George G; Cyganek. Lukas L; Zimmermann. Wolfram H WH; Voigt. Niels N

Key Findings

  • Tachypacing of iPSC‑derived atrial cells reproduces key electrical changes of atrial fibrillation
  • Light‑gated f‑Chrimson allows long‑term pacing and modeling of remodeling over days
  • Prolonged pacing also alters potassium currents and temporarily impairs contractile function

Practical Outcomes

  • This research is a technical model for drug discovery, not a usable protocol for biohackers. It offers no actionable guidance on selank or any self‑directed health strategy.

Summary

The study describes a lab technique that uses stem‑cell derived heart cells and light‑activated channels to mimic the electrical changes seen in atrial fibrillation, but it doesn’t provide any direct advice or protocols for using the peptide selank or for personal health improvement.

Abstract

Atrial fibrillation (AF) is associated with tachycardia-induced cellular electrophysiology alterations which promote AF chronification and treatment resistance. Development of novel antiarrhythmic therapies is hampered by the absence of scalable experimental human models that reflect AF-associated electrical remodelling. Therefore, we aimed to assess if AF-associated remodelling of cellular electrophysiology can be simulated in human atrial-like cardiomyocytes derived from induced pluripotent stem cells in the presence of retinoic acid (iPSC-aCM), and atrial-engineered human myocardium (aEHM) under short term (24 h) and chronic (7 days) tachypacing (TP). First, 24-h electrical pacing at 3 Hz was used to investigate whether AF-associated remodelling in iPSC-aCM and aEHM would ensue. Compared to controls (24 h, 1 Hz pacing) TP-stimulated iPSC-aCM presented classical hallmarks of AF-associated remodelling: (i) decreased L-type Ca2+ current (ICa,L) and (ii) impaired activation of acetylcholine-activated inward-rectifier K+ current (IK,ACh). This resulted in action potential shortening and an absent response to the M-receptor agonist carbachol in both iPSC-aCM and aEHM subjected to TP. Accordingly, mRNA expression of the channel-subunit Kir3.4 was reduced. Selective IK,ACh blockade with tertiapin reduced basal inward-rectifier K+ current only in iPSC-aCM subjected to TP, thereby unmasking an agonist-independent constitutively active IK,ACh. To allow for long-term TP, we developed iPSC-aCM and aEHM expressing the light-gated ion-channel f-Chrimson. The same hallmarks of AF-associated remodelling were observed after optical-TP. In addition, continuous TP (7 days) led to (i) increased amplitude of inward-rectifier K+ current (IK1), (ii) hyperpolarization of the resting membrane potential, (iii) increased action potential-amplitude and upstroke velocity as well as (iv) reversibly impaired contractile function in aEHM. Classical hallmarks of AF-associated remodelling were mimicked through TP of iPSC-aCM and aEHM. The use of the ultrafast f-Chrimson depolarizing ion channel allowed us to model the time-dependence of AF-associated remodelling in vitro for the first time. The observation of electrical remodelling with associated reversible contractile dysfunction offers a novel platform for human-centric discovery of antiarrhythmic therapies.

Study Information

Provider

pubmed

Year

2023

Date

2023-12-19T00:00:00.000Z

DOI

10.1093/cvr/cvad143

Citations

23

References

81